In June 2015, the FDA warned that the type 2 diabetes medicines Sitagliptin (and saxagliptin, linagliptin, and alogliptin) may cause joint pain, which can be severe and disabling
That analysis came from a relatively small subpopulation of just 55 patients who underwent whole-body MRI scanning, which showed that the reduction in lean muscle mass with treatment, which raises concerns about loss of physical strength, mobility, and metabolic health, was around 10%
Wear sunscreen Some research suggests that regular sunscreen use prevents skin ageing
GLP-1 medications should be stored in the refrigerator at 36F to 46F (2C to 8C) until first use
The animal data offers a partial explanation
However, retatrutide is most effective at reducing fat mass